Neo-Synalar (NEOMYCIN SULFATE AND FLUOCINOLONE ACETONIDE)
Neo-Synalar (NEOMYCIN SULFATE AND FLUOCINOLONE ACETONIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Neo-Synalar; Generic name: NEOMYCIN SULFATE AND FLUOCINOLONE ACETONIDE; Drug class: Corticosteroid [EPC].
| Brand name | Neo-Synalar |
|---|---|
| Generic name | NEOMYCIN SULFATE AND FLUOCINOLONE ACETONIDE |
| Drug class | Corticosteroid [EPC] |
| Manufacturer | Eurofarma, Inc. |
| Used for | INDICATIONS AND USAGE NEO-SYNALAR ® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. It has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see WARNINGS section) . |
| Dosage | DOSAGE AND ADMINISTRATION NEO-SYNALAR ® cream is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Since NEO-SYNALAR ® cream is a water-washable vanishing cream, it is easily applied and leaves no traces. |
| Warnings | WARNINGS If local infection should continue or become severe, or in the presence of systemic infection, appropriate systemic antibacterial therapy, based on susceptibility testing, should be considered. Because of the concern of nephrotoxicity and ototoxicity associated with neomycin, this combination product should not be used over a wide area or for extended periods of time. There are articles in the current medical literature that indicate an increase in the prevalence of persons sensitive to |
| Active ingredient(s) | FLUOCINOLONE ACETONIDE |
| Route | TOPICAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1141956e-8a4c-4f80-95d1-f15bdb57fdf6 |